Hims & Hers Health

Hims & Hers Health

Health Care Providers & Services
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

$7B

Market Cap • 9/30/2026

2019

(7 years)

Founded

2021

(5 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

21,4

P/S

2,7

P/EBITDA

—

P/OCF

26,4

P/FCF

83,7

P/E

—

BVPS

1,4

EPS

—

Market Cap

Market Cap

7B

EV

7,7B

EV/Revenue

3

EV/EBITDA

-113,7

EV/EBIT

-49,5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0,9%

Total Yield

0,9%

Payout

0%

Retained Earnings

-292,2M

Profitability

Gross Margin

68,4%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

7,1%

Capex/Revenue

7%

Capex/D&A

206,9%

Capex/OCF

68,5%

SBC/OCF

58,3%

% PPE

14,6%

% Goodwill

30,4%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

67,5%

CAGR Op. Income 5Y

15,9%

CAGR Net Income 5Y

14,7%

CAGR EPS 5Y

-2,1%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

0,9

Quick Ratio

0,8

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium